Funding Cures. Saving Lives.
PNOC participating hospitals include:
There has never been a more hopeful time in history to invest in childhood cancer research.
Kids like Kyler deserve more than 499 days.
499 days will premiere at the Flyover Film festival in Louisville, KY at the Kentucky Science Center, on August 1, 2026
“By sharing Kyler's inspiring battle, we strive to raise awareness about the urgent need to support research, foster a compassionate community, drive meaningful change, and illuminate a path toward a future where every pediatric cancer fight is met with hope, a future where we lose no child.” — Jamie Buckner, 499 Days Director & Producer
499 Days is a feature length documentary that chronicles Kyler, a spirited boy from Louisville, KY, diagnosed with DIPG, a rare and aggressive brain cancer. The film features interviews with PNOC Co-founder Dr. Sabine Mueller, and PNOC Investigators Dr. Alyssa Reddy, Dr. Nalin Gupta and NP Carly Hoffman.
Join the 499 Days team in supporting PNOC Foundation’s Lose No Child campaign. Your support will create a future where we lose no child to brain cancer, where kids have safer, less toxic treatments and where more of them would get better, and fewer would suffer harsh, chronic side effects in and after remission.
Building on a decade of PNOC’s leadership and results, our goal is ambitious yet clear: to accelerate research and achieve in 5 years what typically takes a decade.
Why? Because these kids don’t have time.
Lose No Child is a bold and urgent $50 million campaign driving progress to transform treatment, advance research, and develop safer, more effective therapies for kids with brain cancer.
Collaboration, Speed and Hope
Kids with brain cancer don’t have time for business as usual. Neither do we.
“Every year, pediatric brain cancer steals almost 50,000 years of human life in the United States alone. Behind these statistics are countless young lives waiting, hoping, and fighting against a ticking clock. These kids don’t have time for business as usual.
There will be a day in the near future when I can say to families: This used to be an incurable disease, but through true collaboration we now have effective therapies”
Dr Sabine Mueller MD, PhD, MAS
Pediatric neurologist Pediatric
neuro-oncologist
UCSF, PNOC Consortium
Co-Founder & Project Lead
We Are Game-Changers
With a distinctive blend of speed and collaboration, we unite over 300 researchers across 43 leading institutions worldwide
to accelerate breakthroughs in pediatric
brain cancer.
We Fund Dream Teams
Our network brings together oncologists, neurologists, radiologists, biologists, surgeons, geneticists, data analysts, statisticians, patient families, and industry partners—all resolutely committed to eradicating pediatric brain cancer.
We’ve spent the last 10 years building a uniquely collaborative global clinical trial platform that gets results.
Fund our quest for breakthroughs, new and safer
treatments and cures today.
A History-Making FDA Drug Approval for the Most Common Brain Tumor in Kids
For the past decade, our relentless pursuit of breakthrough treatments has led to a landmark FDA drug approval—a game-changing advancement in the fight against pediatric brain cancer. This milestone is just the beginning. Explore our 10-year impact report to see how collaboration, innovation, and bold action are transforming the future of treatment for children.
Through dedication and innovation, we aim to redefine the pace of progress in the fight against the deadliest childhood cancers.
This initiative stands as a beacon of hope, aiming to deliver tailor-made solutions that address the unique challenges of pediatric brain cancer.
More Ways to Make an Impact
DONATE NOW
Make an immediate impact by supporting the fight against pediatric brain cancer. Your donation helps fund research, treatments, and breakthroughs.
MORE WAYS TO GIVE
Looking for different ways to support? From in-kind donations to stocks, crypto, corporate partnerships, and more, explore all the ways you can contribute.
GET IN TOUCH
Have questions or want to discuss how you can help? Reach out to us directly—we’d love to hear from you!
How We Allocate Funds
50%
Clinical Trial Development and Implementation
Purpose: To design, launch, expand and manage new clinical trials.
Details: This includes protocol development, strategies to integrate AI in protocol design and execution, patient recruitment, data collection, regulatory compliance, and trial execution. Emphasizes the importance of well-conducted trials that are both robust and nimble in bringing new therapies to children with brain tumors.
30%
Generating Access to Innovative Therapies
Purpose: To ensure that patients have access to cutting-edge treatments as soon as they become available on a global level.
Details: Supports the launch of international clinical trials, including in low- to middle-income countries, to expand treatment access worldwide.
20%
Development of Predictive Biomarkers and Preclinical Rationale
Purpose: To advance research on predictive biomarkers and preclinical models that guide treatment strategies for pediatric brain tumors.
Details: Focuses on identifying biomarkers that predict treatment response, optimizing early-stage research, and integrating AI-driven approaches to accelerate new therapy development.
FDA Approves Tovorafenib (Day101)
A milestone for children with pediatric low-grade Glioma.
5000
Children are diagnosed
with brain cancer each year.
1%
Pediatric brain cancer
only receives 1% of
federal research funding.
#1
Pediatric brain cancer
is the leading cause of cancer
deaths amongst children.
Hope. Innovation. Action.
We are breaking barriers, transforming treatments, and giving children with brain cancer a future. But we can’t do it alone.
With your support, our doctors, researchers, and specialists can push the boundaries of what’s possible—faster, smarter, and with greater impact.
Join us. Be part of the cure.
Raise awareness and show your support.
Nike Dri-FIT Jersey Blend Performance Tee
Nike Club Fleece Crewneck Sweatshirt
Nike Club Fleece Pullover Hoodie
Nike Printed Dri-FIT Legacy Performance Cap